Inbody Coltd Stock Profit Margin

041830 Stock  KRW 22,250  250.00  1.11%   
InBody CoLtd fundamentals help investors to digest information that contributes to InBody CoLtd's financial success or failures. It also enables traders to predict the movement of InBody Stock. The fundamental analysis module provides a way to measure InBody CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InBody CoLtd stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

InBody CoLtd Company Profit Margin Analysis

InBody CoLtd's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current InBody CoLtd Profit Margin

    
  0.25 %  
Most of InBody CoLtd's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InBody CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, InBody CoLtd has a Profit Margin of 0.2464%. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The profit margin for all Republic of Korea stocks is notably lower than that of the firm.

InBody Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InBody CoLtd's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InBody CoLtd could also be used in its relative valuation, which is a method of valuing InBody CoLtd by comparing valuation metrics of similar companies.
InBody CoLtd is currently under evaluation in profit margin category among its peers.

InBody Fundamentals

About InBody CoLtd Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze InBody CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InBody CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InBody CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with InBody CoLtd

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InBody CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will appreciate offsetting losses from the drop in the long position's value.

Moving together with InBody Stock

  0.67293780 AptaBio TherapeuticsPairCorr

Moving against InBody Stock

  0.55041190 Woori Technology InvPairCorr
The ability to find closely correlated positions to InBody CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InBody CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InBody CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InBody CoLtd to buy it.
The correlation of InBody CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InBody CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InBody CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InBody CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in InBody Stock

InBody CoLtd financial ratios help investors to determine whether InBody Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InBody with respect to the benefits of owning InBody CoLtd security.